Capricor Therapeutics (CAPR) Institutional Ownership $15.04 -0.16 (-1.05%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$15.04 0.00 (0.00%) As of 01/31/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)24TotalInstitutional Inflows(last 12 months)$15.82MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$201.29K Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/31/2025New York State Common Retirement Fund5,800$80K0.0%+625.0%0.013% 1/30/2025 Rhumbline Advisers46,083$636K0.0%+44.4%0.101% 1/17/2025 SG Americas Securities LLC15,317$211K0.0%+74.8%0.034% 1/17/2025 Magnus Financial Group LLC20,000$276K0.0%N/A0.044% 1/15/2025 Krilogy Financial LLC20,800$287K0.0%N/A0.046% 12/26/2024JPMorgan Chase & Co.56,199$855K0.0%+419.5%0.124% 11/20/2024Virtu Financial LLC30,112$458K0.0%N/A0.066% 11/19/2024Barclays PLC36,296$552K0.0%+106.6%0.080% 11/16/2024Geode Capital Management LLC638,189$9.71M0.0%-0.5%1.405% 11/15/2024Barclays PLC36,296$552K0.0%+106.6%0.080% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Sphera Funds Management LTD.61,698$938K0.1%N/A0.136% 11/15/2024State Street Corp512,313$7.79M0.0%+27.8%1.128% 11/15/2024Sassicaia Capital Advisers LLC12,600$192K0.6%N/A0.028% 11/15/2024Point72 Asset Management L.P.250,204$3.81M0.0%N/A0.551% 11/14/2024PFM Health Sciences LP152,779$2.32M0.1%N/A0.336% 11/14/2024Fred Alger Management LLC26,241$399K0.0%N/A0.058% 11/13/2024BNP Paribas Financial Markets17,699$269K0.0%+868.7%0.039% 11/13/2024FMR LLC24,344$370K0.0%N/A0.054% 11/13/2024The Manufacturers Life Insurance Company10,558$161K0.0%N/A0.023% 11/12/2024 Activest Wealth Management5,000$76K0.0%-50.0%0.011% 11/6/2024Main Street Financial Solutions LLC22,650$345K0.0%-17.6%0.050% 11/6/2024Oppenheimer & Co. Inc.68,408$1.04M0.0%+25.2%0.151% 10/3/2024 SG Americas Securities LLC8,765$133K0.0%N/A0.027% 8/14/2024Marshall Wace LLP89,314$426K0.0%N/A0.279% 8/9/2024Renaissance Technologies LLC137,500$656K0.0%+158.7%0.430% 8/8/2024Main Street Financial Solutions LLC27,500$131K0.0%+37.5%0.086% 8/1/2024 Rhumbline Advisers30,886$147K0.0%N/A0.097% 7/26/2024Bank of New York Mellon Corp79,782$381K0.0%+12.8%0.249% 5/10/2024Vanguard Group Inc.1,365,903$9.27M0.0%+17.2%4.336% 5/1/2024BNP Paribas Financial Markets5,827$40K0.0%N/A0.018% 2/7/2024Jump Financial LLC52,800$258K0.0%N/A0.171% 12/6/2023Citigroup Inc.61,591$211K0.0%N/A0.200% 7/31/2023LPL Financial LLC78,436$375K0.0%N/A0.310% 5/1/2023Virtu Financial LLC16,895$71K0.0%N/A0.067% 11/7/2022Jump Financial LLC22,600$136K0.0%N/A0.093% 10/18/2022Bailard Inc.33,601$202K0.0%+12.8%0.138% 7/27/2022Bailard Inc.29,801$104K0.0%N/A0.123% 4/20/2022 Selective Wealth Management Inc.213,494$732K0.3%N/A0.878% 11/16/2021Two Sigma Securities LLC11,511$46K0.0%N/A0.050% 11/15/2021GSA Capital Partners LLP96,632$388K0.0%-14.0%0.420% New crypto boom will be greatest in history (Ad)Urgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is the moment American crypto investor’s have been waiting for."Click here now for full details. 11/15/2021HighTower Advisors LLC53,960$215K0.0%+206.6%0.234% 11/9/2021Barclays PLC6,330$25K0.0%+246.1%0.027% 11/9/2021BlackRock Inc.300,201$1.21M0.0%-1.6%1.304% 8/17/2021Oracle Investment Management Inc.1,166,249$5.98M0.8%-41.7%5.098% 8/16/2021State Street Corp71,748$368K0.0%N/A0.314% 8/13/2021Northern Trust Corp104,251$535K0.0%+7.5%0.456% 8/13/2021Geode Capital Management LLC184,990$948K0.0%+7.9%0.809% 8/13/2021Vanguard Group Inc.923,233$4.74M0.0%+1.2%4.035% 8/11/2021Susquehanna Fundamental Investments LLC16,500$85K0.0%-49.1%0.072% 8/5/2021GSA Capital Partners LLP112,364$576K0.1%+684.6%0.491% 5/18/2021Millennium Management LLC22,390$105K0.0%-54.6%0.098% 5/18/2021Oracle Investment Management Inc.1,999,464$9.36M1.4%N/A8.770% 5/12/2021Northern Trust Corp96,941$453K0.0%-29.1%0.425% 5/12/2021M Holdings Securities Inc.20,000$94K0.0%N/A0.088% 5/12/2021Geode Capital Management LLC171,415$802K0.0%+40.7%0.752% 5/10/2021HighTower Advisors LLC12,300$57K0.0%-25.9%0.054% 5/10/2021GSA Capital Partners LLP14,321$67K0.0%-81.9%0.063% 5/7/2021BlackRock Inc.347,103$1.62M0.0%+1.2%1.523% 5/3/2021Trellus Management Company LLC270,000$1.26M0.7%N/A1.184% 2/11/2021Northern Trust Corp136,814$469K0.0%-9.6%0.669% 2/9/2021Bank of New York Mellon Corp89,249$306K0.0%+47.7%0.436% 2/5/2021BlackRock Inc.343,011$1.18M0.0%+0.4%1.677% 2/4/2021GSA Capital Partners LLP79,091$271K0.0%N/A0.387% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, 28 institutional investors and hedge funds held shares of Capricor Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($9.71M), Vanguard Group Inc. ($9.27M), State Street Corp ($7.79M), Point72 Asset Management L.P. ($3.81M), PFM Health Sciences LP ($2.32M), Oppenheimer & Co. Inc. ($1.04M), and Sphera Funds Management LTD. ($938K).Learn more on CAPR's institutional investors. What percentage of Capricor Therapeutics stock is owned by institutional investors? 21.68% of Capricor Therapeutics stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics stock? Of the 26 institutional investors that purchased Capricor Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($250.20K), Vanguard Group Inc. ($200.50K), PFM Health Sciences LP ($152.78K), State Street Corp ($111.29K), Marshall Wace LLP ($89.31K), Renaissance Technologies LLC ($84.35K), and LPL Financial LLC ($78.44K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 1,504,714 shares in the last 24 months. This purchase volume represents approximately $16.47M in transactions. Which Capricor Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Capricor Therapeutics stock in the last 24 months: Activest Wealth Management ($5K), Main Street Financial Solutions LLC ($4.85K), and Geode Capital Management LLC ($3.38K). How much institutional selling is happening at Capricor Therapeutics? Institutional investors have sold a total of 13,234 shares in the last 24 months. This volume of shares sold represents approximately $201.29K in transactions. Related Companies ARWR Institutional Ownership HCM Institutional Ownership MIRM Institutional Ownership PTGX Institutional Ownership JANX Institutional Ownership LGND Institutional Ownership VERA Institutional Ownership HRMY Institutional Ownership SUPN Institutional Ownership CNTA Institutional Ownership This page (NASDAQ:CAPR) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
